承担课题研究 1. 上海交通大学“医工交叉研究基金”，肺部GGN患者血清中免疫相关糖蛋白糖型的生物标志物研究（2016-2018） 2. 国家自然基金，面上项目，课题编号：81372523，STAT3异构体的表达与I期非小细胞肺癌预后的关联性分析（2013-2016） 3. 国家卫生部课题，课题编号：W2013FZ26，非小细胞肺癌循环肿瘤细胞在术后复发监控中的价值研究（2014-2015） 4. 上海市科委项目，课题编号：10411967800，IIIa期N2非小细胞肺癌分期方法及治疗策略的临床研究（2010-2013） 发表的文章及著作 1. 赵珩, 吴献忠, 吴正亮, 等. 选择性支气管动脉药物灌注治疗支气管肺癌[J]. 中华胸心血管外科杂志,1991,07(2):124-124. 2. 周允中, 赵珩, 孙德魁, 蓝之源, 赵大方, 黄偶麟. 胸壁缺损修补重建方法探讨[J]. 中华胸心血管外科杂志,1994(01):51-52+66+96-97. 3. 赵珩, 黄偶麟, 屈宁, 周允中, 杨异. 纵隔恶性畸胎瘤的外科治疗（附35例报告）[J].中华胸心血管外科杂志,1995(01):14-15. 4. 赵珩.肺移植肺脏保护方法的研究进展[J].中华胸心血管外科杂志,1995(04):244-245. 5. Zhao H, Yamamoto Y, Ohno K. Surgical treatment of 102 cases with primary tracheal tumors. 日本呼吸器外科学会杂志 1995；9（3）：236（458）. 6. Zhao H, Hua TC, Zhou YZ, Wang QF, Yang Y, Bao LL. Cryopreservation and transplantation of dog trachea. Ann N Y Acad Sci. 1998 Sep 11;858:270-5. 7. 赵珩,吉春宇,杨异,陈文虎,黄偶麟.小细胞肺癌的外科治疗[J].中国肺癌杂志,2001(06):410-412. 8. 赵珩, 杨异, 周允中. 同种异体气管材料保存及移植实验研究 [J] . 中华胸心血管外科杂志,2002,18( 4 ): 230-232. 9. 赵珩.人工气管重建气管研究的进展[J].中华胸心血管外科杂志,2004(02):5-6. 10. 谭强,赵珩,潘银根,施建新,沙慧芳,周允中.组织工程化骨修复胸壁缺损的实验研究[J].中华胸心血管外科杂志,2004(03):46-48. 11. 赵珩,茅腾.食管癌肉瘤的诊断与治疗(附7例报道)[J].上海医学,2004(10):759-760. 12. 吉春宇,杨异,赵珩,陈文虎.手术对肺癌患者外周血T细胞亚群的影响[J].上海医学,2004(10):763-764. 13. 赵珩,付世杰.中晚期非小细胞肺癌外科治疗现状[J].上海医学,2005(06):447-450. 14. 杨异,赵珩,陈文虎,冯久贤,包国良.手术对肺癌患者外周血中癌细胞端粒酶活性的影响[J].肿瘤,2006(09):863-865. 15. 赵珩,澹台冀徵,范利民.气管疾病外科手术治疗413例[J].中华胸心血管外科杂志,2008(04):231-232. 16. 郭翔,赵珩.组织工程化气管上皮细胞培养的技术进展[J].中国组织工程研究与临床康复,2009,13(24):4730-4733. 17. [1]刘政呈,赵珩.组织工程化气管的研究及应用现状[J].中华胸心血管外科杂志,2009(04):281-283. 18. Sun J, Zhang J, Zhao H, Shen J, Gu A, Han B. Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma: Experience of a single institution in China. Thorac Cancer. 2010 May;1(1):28-34. 19. Liu ZC, Zhao H. Titanium internal fixation system used for sternum reconstruction after resection of chondrosarcoma. Chin Med J (Engl). 2010 Sep;123(18):2621-2. 20. 孙加源,韩宝惠,张俭,赵珩,戚大江,沈洁,顾爱琴.超声支气管镜引导下的经支气管针吸活检对肺癌的诊断价值[J].中国肺癌杂志,2010,13(05):432-437. 21. 孙加源,韩宝惠,赵珩,张俭,冯久贤,张杰,沙慧芳,戚大江,顾爱琴,沈洁,冯运.超声支气管镜引导下经支气管针吸活检70例临床分析[J].中华结核和呼吸杂志,2010(10):738-741. 22. 刘政呈,郭翔,赵珩.分离扩增肋软骨细胞在三维支架上的种植与培养[J].中国组织工程研究与临床康复,2010,14(34):6297-6300. 23. 刘政呈,郭翔,赵珩.三维支架与肋软骨细胞体外及体内培养构建组织工程化气管[J].中华胸心血管外科杂志,2011(07):432-436. 24. Sun Jia-Yuan,Zhao Heng,Zhang Jie,Wang Xiang-Dong,Han Bao-Hui. First 30 endobronchial ultrasound-guided transbronchial needle aspirations: a single institution's early experience.[J]. Chinese medical journal,2011,124(12). 25. 郭翔,赵珩.三维支架材料与脂肪干细胞的生物相容性[J].中国组织工程研究与临床康复,2011,15(38):7080-7084. 26. 赵珩。中国电视胸腔镜外科发展简史。中国微创外科杂志，2011,11(4): 227-9. 27. 葛晓晓,澹台冀澂,刘友如,赵珩,姜丽岩.TTF-1在Ⅰ期非小细胞肺癌中的表达与预后[J].中华胸心血管外科杂志,2012(11):662-664. 28. 郭翔，管欣，赵珩。脂肪干细胞与三维支架体内外培养构建的组织工程化气管[J]，中国组织工程研究，2012，16(41)：7658-7663. 29. 姚烽，周俊，仲晨曦，杨煜，赵珩。62例肺类癌的外科治疗及预后[J]，中华胸心血管外科杂志,2012;28(4):233-236. 30. 吉春宇，赵珩，方文涛，陈文虎。60例肺多形性癌的外科治疗。中华胸心血管外科杂志，2012,28(11):655-658。 31. Zhong CX, Yao F, Zhao H, Shi JX, Fan LM. Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years' experience with 131 patients. Chin Med J. 2012, 125(7): 3022-6. 32. 仲晨曦，赵珩，澹台冀澂，姚烽，范利民，陈文虎。胸腔镜手术治疗肺单纯性磨玻璃样病灶。中华胸心血管外科杂志，2012,28(11):227-9. 33. Feng Yao,Tiejun Zhao,Chenxi Zhong,Ji Zhu,Heng Zhao. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma[J]. Tumor Biology,2013,34(1). 34. 施建新, 赵珩, 潘旭峰, 等.  双肺移植治疗终末期良性肺病40例 [J] . 中华胸心血管外科杂志,2013,29( 05 ): 286-289. 35. 赵珩,姚烽,张冬坤.机器人肺叶切除治疗非小细胞肺癌:患者长期随访结果解析[J].循证医学,2013,13(02):103-105. 36. Ye B, Tantai JC, Li W, Ge XX, Feng J, Cheng M, Zhao H. Video-assisted thoracoscopic surgery versus robotic-assisted thoracoscopic surgery in the surgical treatment of Masaoka stage I thymoma. World J Surg Oncol. 2013 Jul 17;11:157. 37. Zhong C, Yao F, Zhao H. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer. Ann Thorac Surg. 2013 Mar;95(3):987-92. 38. Yang Zhao, Heng Zhao, Dingzhong Hu, Limin Fan. Jiaoxin Shi, Wentao Fang Surgical treatment and Prognosis of Thymic Squamous of 105 Cases. Ann Thorac Surg. 2013;96:1019-24. 39. 叶波,李望,冯健,陈铭,澹台冀澂,赵珩.人工智能辅助胸外科手术25例[J].中华胸心血管外科杂志,2013,29(08):460-462. 40. 叶波,冯健,陈铭,澹台冀激,陈勇,赵珩,施建新.PDS Ⅱ可吸收缝线编网胸壁重建23例[J].中华胸心血管外科杂志,2013,29(10):595-596+613. 41. 沈宇舟,潘旭峰,赵珩.非小细胞肺癌术后化疗患者药物利用调查[J].中国药师,2014,17(02):293-295. 42. 陈铭,赵珩,吴卫华,杨骏.右心室射血分数与肺切除术后并发症的相关性分析[J].中国临床医学,2014,21(01):16-17+20. 43. 杨海堂,赵珩.MSCs老化研究进展[J].中国修复重建外科杂志,2014,28(08):1037-1042. 44. Ye B, Tantai JC, Ge XX, Li W, Feng J, Cheng M, Shi JX, Zhao H. Surgical techniques for early-stage thymoma: video-assisted thoracoscopic thymectomy versus transsternal thymectomy. J Thorac Cardiovasc Surg. 2014 May;147(5):1599-603. 45. Ye B, Li W, Ge XX, Feng J, Ji CY, Cheng M, Tantai JC, Zhao H. Surgical treatment of early-stage thymomas: robot-assisted thoracoscopic surgery versus transsternal thymectomy. Surg Endosc. 2014 Jan;28(1):122-6. 46. Ye B, Feng J, Pan X, Yang Y, Ji C, Cheng M, Cheng Y, Shi J, Zhao H. Genetic variant of single-nucleotide polymorphism is associated with risk of esophageal squamous cell carcinoma. Genet Test Mol Biomarkers. 2014 Jan;18(1):45-9. 47. Ye B, Cheng M, Ge XX, Geng JF, Li W, Feng J, Hu DZ, Zhao H. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas. World J Surg Oncol. 2014 Feb 21;12:42. 48. Shen Y, Pan X, Zhao H. The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer. Biochem Biophys Res Commun. 2014 Aug 15;451(1):119-25. 49. Huang P, Ye B, Yang Y, Tantai JC, Zhao H. Experience with the "da Vinci" robotic system for early-stage thymomas: Report of 23 cases. Thorac Cancer. 2014 Jul;5(4):325-9. 50. Huang P, Cao K, Zhao H. Screening of critical genes in lung adenocarcinoma via network analysis of gene expression profile. Pathol Oncol Res. 2014 Oct;20(4):853-8. 51. Yang H, Tan Q, Zhao H. Progress in various crosslinking modification for acellular matrix. Chin Med J (Engl). 2014;127(17):3156-64. 52. Yang H, Tantai J, Zhao H. Clinical experience with titanium mesh in reconstruction of massive chest wall defects following oncological resection. J Thorac Dis 2015;7(7):1227-1234.   53. Zhao Y, Chen H, Shi J, Fan L, Hu D, Zhao H. The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma. European Association for Cardio-thoracic Surgery 2015;48(5):698-704. 54. Yang H, Yao F, Zhao Y, Zhao H. Clinical outcomes of surgery after induction treatment in patients with pathologically proven n2-positive stage iii non-small cell lung cancer. Journal of thoracic disease 2015;7(9):1616-1623. 55. Xu L, Ji JJ, Le W, Xu YS, Dou D, Pan J, Jiao Y, Zhong T, Wu D, Wang Y, Wen C, Xie GQ, Yao F, Zhao H, Fan YS, Chin YE. The STAT3 HIES mutation is a gain-of-function mutation that activates genes via AGG-element carrying promoters. Nucleic Acids Res. 2015 Oct 15;43(18):8898-912. 56. Tantai JC, Pan XF, Zhao H. Network analysis of differentially expressed genes reveals key genes in small cell lung cancer. European review for medical and pharmacological sciences 2015;19(8):1364-1372. 57. Sun J, Yang H, Teng J, Zhang J, Zhao H, Garfield DH, Han B. Determining factors in diagnosing pulmonary sarcoidosis by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Surg. 2015 Feb;99(2):441-5. 58. Huang P, Ye B, Yang Y, Shi J, Zhao H. Microrna-181 functions as a tumor suppressor in non-small cell lung cancer (nsclc) by targeting bcl-2. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015;36(5):3381-3387. 59. Hao S, Li Z, Fang W, Mao T, Zhao H, Zhong C. Adaption of surgical procedure in the treatment of submucosal esophageal cancer. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2015;18(9):885-888. 60. Fu S, Fan L, Pan X, Sun Y, Zhao H. Integrin alphav promotes proliferation by activating erk 1/2 in the human lung cancer cell line a549. Mol Med Rep 2015;11(2):1266-1271. 61. Pan X, Chen Y, Shi J, Zhao H, Chen H. Robotic Assisted Extended Sleeve Lobectomy After Neoadjuvant Chemotherapy. Ann Thorac Surg. 2015 Dec;100(6):e129-31. 62. 郝曙光,李志刚,方文涛,茅腾,赵珩,仲晨曦.T_1b期食管癌手术方式的选择[J].中华胃肠外科杂志,2015,18(09):885-888. 63. 叶波,曹克坚,范利民,杨骏,胡定中,施建新,李志刚,方文涛,赵珩,陈海泉.临床T1aN0M0肺腺癌淋巴结转移预测因素分析[J].中华胸部外科电子杂志,2015,2(01):29-34. 64. Zhao Y, Shi J, Fan L, Hu D, Yang J, Zhao H. Surgical treatment of thymoma: an 11-year experience with 761 patients. Eur J Cardiothorac Surg. 2016 Apr;49(4):1144-9. 65. Zhao Y, Shi J, Fan L, Yang J, Hu D, Zhao H. Evaluation of the proposed International Association for the Study of Lung Cancer (IASLC)/International Thymic Malignancies Interest Group (ITMIG) staging revisions in thymic well-differentiated neuroendocrine carcinoma patients. Eur J Cardiothorac Surg. 2016 Feb;49(2):569-73. 66. Yao F, Yang H, Zhao H. Single-stage bilateral pulmonary resections by video-assisted thoracic surgery for multiple small nodules. J Thorac Dis. 2016 Mar;8(3):469-75. 67. Yang Y, Gao W, Zhao H, Yang Y, Shi J, Sun Y, Hu D. Risk factors and consequences of perioperative reoperation in patients undergoing pulmonary resection surgery. Surgery. 2016 Feb;159(2):591-601. 68. Yang H, Yao F, Tantai J, Zhao Y, Tan Q, Zhao H. Resected Tracheal Adenoid Cystic Carcinoma: Improvements in Outcome at a Single Institution. Ann Thorac Surg. 2016 Jan;101(1):294-300. 69. Yang H, Sun Y, Yao F, Yu K, Gu H, Han B, Zhao H. Surgical Therapy for Bilateral Multiple Primary Lung Cancer. Ann Thorac Surg. 2016 Mar;101(3):1145-52.   70. Tantai JC, Zhang Y, Zhao H. Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling. Mol Med Rep. 2016 Feb;13(2):1097-104. 71. Sun Y, Yang Y, Chen Y, Pan X, Yang Y, Gao W, Zhao H, Shi J. Translocation of left inferior lobe pulmonary artery to the pulmonary artery trunk for central type non-small cell lung cancers. J Thorac Dis. 2016 May;8(5):826-32. 72. Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B. Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma. Onco Targets Ther. 2016 Jul 25;9:4583-91. 73. Pan X, Gu C, Wang R, Zhao H, Shi J, Chen H. Initial Experience of Robotic Sleeve Resection for Lung Cancer Patients. Ann Thorac Surg. 2016 Dec;102(6):1892-1897. 74. Luo J, Wang R, Han B, Zhang J, Zhao H, Fang W, Luo Q, Yang J, Yang Y, Zhu L, Chen T, Cheng X, Huang Q, Wang Y, Zheng J, Chen H. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma. J Cancer Res Clin Oncol. 2016 Aug;142(8):1837-45. 75. Luo J, Huang Q, Wang R, Han B, Zhang J, Zhao H, Fang W, Luo Q, Yang J, Yang Y, Zhu L, Chen T, Cheng X, Wang Y, Zheng J, Wu H, Xia W, Chen H. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB. J Cancer Res Clin Oncol. 2016 Sep;142(9):2031-40. 76. Lian S, Huang Y, Yang H, Zhao H. Serum carbohydrate antigen 12-5 level enhances the prognostic value in primary adenosquamous carcinoma of the lung: a two-institutional experience. Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):419-24. 77. Jiang L, Huang J, Higgs BW, Hu Z, Xiao Z, Yao X, Conley S, Zhong H, Liu Z, Brohawn P, Shen D, Wu S, Ge X, Jiang Y, Zhao Y, Lou Y, Morehouse C, Zhu W, Sebastian Y, Czapiga M, Oganesyan V, Fu H, Niu Y, Zhang W, Streicher K, Tice D, Zhao H, Zhu M, Xu L, Herbst R, Su X, Gu Y, Li S, Huang L, Gu J, Han B, Jallal B, Shen H, Yao Y. Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer. PLoS Genet. 2016 Apr 19;12(4):e1005895. 78. Jiang WY, Wang R, Pan XF, Shen YZ, Chen TX, Yang YH, Shao JC, Zhu L, Han BH, Yang J, Zhao H. Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma. J Thorac Dis. 2016 Sep;8(9):2610-2616. 79. Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z. Clinical outcomes of patients with metachronous second primary lung adenocarcinomas. Onco Targets Ther. 2017 Jan 10;10:295-302. 80. Wang Y, Wang R, Zheng D, Han B, Zhang J, Zhao H, Luo J, Zheng J, Chen T, Huang Q, Sun Y, Chen H. Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection. J Cancer Res Clin Oncol. 2017 Jun;143(6):1043-1051. 81. Zhao Y, Gu H, Fan L, Han K, Yang J, Zhao H. Comparison of clinical features and survival between thymic carcinoma and thymic carcinoid patients. Eur J Cardiothorac Surg. 2017 Jul 1;52(1):33-38. 82. Pan X, Gu C, Wang R, Zhao H, Yang J, Shi J. Transmanubrial osteomuscular sparing approach for resection of cervico-thoracic lesions. J Thorac Dis. 2017 Sep;9(9):3062-3068. 83. Zhang C, Yang H, Zhao H, Lang B, Yu X, Xiao P, Zhang X. Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience. J Thorac Dis. 2017 Jan;9(1):151-158. 84. Wang Y, Wang R, Zheng D, Han B, Zhang J, Zhao H, Luo J, Zheng J, Chen T, Huang Q, Sun Y, Chen H. The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. J Cancer Res Clin Oncol. 2017 Oct;143(10):2095-2104. 85. Sun Y, Gu C, Shi J, Fang W, Luo Q, Hu D, Fu S, Pan X, Chen Y, Yang Y, Yang H, Zhao H, Chen H. Reconstruction of mediastinal vessels for invasive thymoma: a retrospective analysis of 25 cases. J Thorac Dis. 2017 Mar;9(3):725-733. 86. Luo J, Wang R, Han B, Zhang J, Zhao H, Fang W, Luo Q, Yang J, Yang Y, Zhu L, Chen T, Cheng X, Huang Q, Wang Y, Zheng J, Chen H. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma. Oncotarget. 2017 Jan 24;8(4):7050-7058. 87. Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H. Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection. Onco Targets Ther. 2017 Jan 6;10:239-245. 88. Chen T, Luo J, Wang R, Gu H, Gu Y, Huang Q, Wang Y, Zheng J, Gu C, Pan X, Yang J, Yang Y, Zhao H. Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm. Oncotarget. 2017 Mar 22;8(39):66576-66583. 89. Zhao Y, Yao F, Tang W, Gu H, Zhao H. S100A14 rs11548103 G>A polymorphism is associated with a decreased risk of esophageal cancer in a Chinese population. Oncotarget. 2017 Sep 14;8(49):86917-86923. 90. Wang FH, Wang Y, Sun GP, Chen JH, Lin YC, Liu W, Zheng RS, Chen J, Zhang HL, Lan HT, Qi J, Liu YQ, Deng YM, Zhao H, Xiong JP, Xu Q, Jiang WQ, Li YH. Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial. Cancer. 2017 Oct 15;123(20):3986-3994. 91. Wang Y, Zheng D, Zheng J, Huang Q, Han B, Zhang J, Zhao H, Chen H. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy. J Cancer Res Clin Oncol. 2018 Jun;144(6):1015-1023. 92. Pan X, Yang J, Fu S, Zhao H. Application of ex vivo lung perfusion (EVLP) in lung transplantation. J Thorac Dis. 2018 Jul;10(7):4637-4642. 93. Yue D, Xu S, Wang Q, Li X, Shen Y, Zhao H, Chen C, Mao W, Liu W, Liu J, Zhang L, Ma H, Li Q, Yang Y, Liu Y, Chen H, Wang C. Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial. Lancet Respir Med. 2018 Nov;6(11):863-873. 94. Yang J, Pan X, Fu S, Zhao H. Pulmonary retransplantation. J Thorac Dis. 2018 Jul;10(7):4632-4636. 95. Li H, Jiang G, Bölükbas S, Chen C, Chen H, Chen K, Chen J, Cui X, Fang W, Gao S, Gilbert S, Fu J, Fu X, Hida Y, Li S, Li X, Li Y, Li H, Li Y, Liu D, Liu L, He J, He J, Marulli G, Oizumi H, de Perrot M, Petersen RH, Shargall Y, Sihoe A, Tan Q, Wang Q, Xu S, Yang M, Yang Y, Yu Z, Zhang L, Zhang X, Zhao H, Zhi X. The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery. J Thorac Dis. 2018 May;10(5):3039-3053. 96. Yang H, Xu J, Yao F, Liang S, Zhao H. Analysis of unexpected small cell lung cancer following surgery as the primary treatment. J Cancer Res Clin Oncol. 2018 Dec;144(12):2441-2447. 97. Gu C, Pan X, Chen Y, Yang J, Zhao H, Shi J. Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer. Eur J Cardiothorac Surg. 2018 Mar 1;53(3):648-655. 98. Wang Y, Xu J, Han B, Luo Q, Zhao H, Lv C, Wang J, Liu J, Fu X. The role of prophylactic cranial irradiation in surgically resected combined small cell lung cancer: a retrospective study. J Thorac Dis. 2018 Jun;10(6):3418-3427. 99. Chen T, Luo J, Wang R, Gu H, Gu Y, Huang Q, Wang Y, Zheng J, Yang Y, Zhao H. Prognosis of limited resection versus lobectomy in elderly patients with invasive lung adenocarcinoma with tumor size less than or equal to 2 cm. J Thorac Dis. 2018 Apr;10(4):2231-2239. 100. Huang Q, Wang R, Gu C, Pan C, Zhao H, Luo Q, Wang Y, Zheng J, Chen H. Appropriate lymphadenectomy significantly reduced recurrence after segmentectomy for patients with non-small cell lung cancer. J Thorac Dis. 2018 Mar;10(3):1919-1926. 101. Zhou W, Liu T, Saren G, Liao L, Fang W, Zhao H. Comprehensive analysis of differentially expressed long non-coding RNAs in non-small cell lung cancer. Oncol Lett. 2019 Aug;18(2):1145-1156. 102. Xiong L, Li R, Sun J, Lou Y, Zhang W, Bai H, Wang H, Shen J, Jing B, Shi C, Zhong H, Gu A, Jiang L, Shi J, Fang W, Zhao H, Zhang J, Wang J, Ye J, Han B. Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study. Oncologist. 2019 Feb;24(2):157-e64. 103. Yang H, Liang SQ, Xu D, Yang Z, Marti TM, Gao Y, Kocher GJ, Zhao H, Schmid RA, Peng RW. HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer. Oncogenesis. 2019 Aug 20;8(9):45. 104. Chen C, Fu S, Ni Q, Yiyang W, Pan X, Jing J, Zhao H, Rui W. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size. Med Sci Monit. 2019 Nov 27;25:9003-9011. 105. Zhong C, Fan L, Li Z, Yao F, Zhao H. SREBP2 is upregulated in esophageal squamous cell carcinoma and co‑operates with c‑Myc to regulate HMGCR expression. Mol Med Rep. 2019 Oct;20(4):3003-3010. 106. Qian J, Xu J, Wang S, Qian F, Yang W, Zhang B, Zhang Y, Nie W, Lou Y, Lu J, Zhang X, Zhang W, Chu T, Zhong H, Fang W, Zhao H, Han B. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy. Ann Surg Oncol. 2019 Aug;26(8):2392-2400. 107. Zhang Z, Feng H, Zhao H, Hu J, Liu L, Liu Y, Li X, Xu L, Li Y, Lu X, Fu X, Yang H, Liu D. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study. J Thorac Dis. 2019 May;11(5):1838-1848. 108. Chen B, Wang X, Yu X, Xia WJ, Zhao H, Li XF, Liu LX, Liu Y, Hu J, Fu XN, Li Y, Xu YJ, Liu DR, Yang HY, Xu L, Jiang F. Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational study. Thorac Cancer. 2019 Mar;10(3):533-542.   109. Chen B, Xia W, Wang Z, Zhao H, Li X, Liu L, Liu Y, Hu J, Fu X, Li Y, Xu Y, Liu D, Yang H, Xu L, Jiang F. Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China. J Cancer Res Clin Oncol. 2019 Nov;145(11):2771-2777. 110. Zou X, Yao F, Yang F, Zhang F, Xu Z, Shi J, Kuno A, Zhao H, Zhang Y. Glycomic Signatures of Plasma IgG Improve Preoperative Prediction of the Invasiveness of Small Lung Nodules. Molecules. 2019 Dec 20;25(1):28. 111. Zhao L, Zhao Y, Guo JD, Zeng Y, Yao F, Liu MN, Wang JM, Lv CX, Liu J, Fu XL, Zhao H, Cai XW. Effective Radiotherapy in Tracheobronchial Adenoid Cystic Carcinoma With Positive Surgical Margin. Ann Thorac Surg. 2020 Dec 24:S0003-4975(20)32139-1. 112. Xu Y, Guo Z, Liu R, Wang H, Wang S, Weder W, Pan Y, Wu J, Zhao H, Luo Q, Tan Q. Bioengineered carina reconstruction using In-Vivo Bioreactor technique in human: proof of concept study. Transl Lung Cancer Res. 2020 Jun;9(3):705-712. 113. Zhou W, Yang J, Saren G, Zhao H, Cao K, Fu S, Pan X, Zhang H, Wang A, Chen X. HDAC6-specific inhibitor suppresses Th17 cell function via the HIF-1α pathway in acute lung allograft rejection in mice. Theranostics. 2020 May 21;10(15):6790-6805. 114. Yang H, Xu D, Yang Z, Yao F, Zhao H, Schmid RA, Peng RW. Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma. Cancers (Basel). 2020 Aug 17;12(8):2310. 115. Fan L, Yang H, Yu L, Wang Z, Ye J, Zhao Y, Cai D, Zhao H, Yao F. Multicenter, prospective, observational study of a novel technique for preoperative pulmonary nodule localization. J Thorac Cardiovasc Surg. 2020 Aug;160(2):532-539.e2. 116. Li X, Li X, Fu X, Liu L, Liu Y, Zhao H, Li Y, Hu J, Xu L, Liu D, Yang H, Zhang X. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients. Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1874-1881. 117. Dell'Amore A, Chen L, Monaci N, Campisi A, Wang Z, Mammana M, Pangoni A, Zhao H, Schiavon M, Yao F, Rea F. Total Lung-sparing Surgery for Tracheobronchial Low-grade Malignancies. Ann Thorac Surg. 2021 Aug;112(2):450-458. 118. Zhao J, Li W, Wang M, Liu L, Fu X, Li Y, Xu L, Liu Y, Zhao H, Hu J, Liu D, Shen J, Yang H, Li X. Video-assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non-small cell lung cancer patients. Thorac Cancer. 2021 Jan;12(1):21-29. 119. Chen L, Campisi A, Wang Z, Dell'Amore A, Ciarrocchi AP, Zhao H, Stella F, Yao F. Left secondary carinal resection and reconstruction for low-grade bronchial malignancies. JTCVS Tech. 2021 May 19;8:196-201. 120. Xu J, He T, Wu Y, Cao J, Han X, Liu L, Fu X, Li Y, Li X, Xu L, Liu Y, Zhao H, Liu D, Peng X, Hu J. VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis. Clin Lung Cancer. 2021 Jun 24:S1525-7304(21)00158-3. 121. Campisi A, Chen L, Dell'Amore A, Ciarrocchi AP, Wang Z, Zhao H, Stella F, Yao F. Lung sparing left secondary carina resection for low-grade tumors: a single-center study. Updates Surg. 2021 Jul 6. 122. Fan L, Yang H, Han K, Zhao Y, Gao W, Schmid RA, Yao F, Zhao H. Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination. Front Surg. 2021 Jun 23;8:679565. 123. Xu J, Ni H, Wu Y, Cao J, Han X, Liu L, Fu X, Li Y, Li X, Xu L, Liu Y, Zhao H, Liu D, Peng X, Hu J. Perioperative comparison of video-assisted thoracic surgery and open lobectomy for pT1-stage non-small cell lung cancer patients in China: a multi-center propensity score-matched analysis. Transl Lung Cancer Res. 2021 Jan;10(1):402-414. 124. Yang H, Al-Hurani MF, Xu J, Fan L, Schmid RA, Zhao H, Yao F. pN1 but not pN0/N2 predicts survival benefits of prophylactic cranial irradiation in small-cell lung cancer patients after surgery. Ann Transl Med. 2021 Apr;9(7):562. d 125. Zhang CC, Hou RP, Xia WY, Zeng WQ, Liu J, Wang JM, Lv CX, Luo QQ, Zhao H, Yu W, Zhang Q, Zhu ZF, Cai XW, Feng W, Fu XL. Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study. Lung Cancer. 2021 Jun;156:100-108. 126. Liang N, Li B, Jia Z, Wang C, Wu P, Zheng T, Wang Y, Qiu F, Wu Y, Su J, Xu J, Xu F, Chu H, Fang S, Yang X, Wu C, Cao Z, Cao L, Bing Z, Liu H, Li L, Huang C, Qin Y, Cui Y, Han-Zhang H, Xiang J, Liu H, Guo X, Li S, Zhao H, Zhang Z. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomed Eng. 2021 Jun;5(6):586-599. 著作 1. 胸壁肿瘤，《临床胸部肿瘤学》，山东科学技术出版社，1995年，参编 2. 恶性肿瘤肺转移及转移性肺癌外科治疗的探讨及评价，肿瘤侵犯胸内脏器的手术治疗，《肺癌现代治疗》，上海医科大学出版社，1998年，参编 3. 气管肿瘤，《肿瘤外科治疗学》，江苏科学技术出版社，2000年，参编 4. 肺部恶性肿瘤，肺大疱，《顾恺时胸心血管外科手术学》，上海科学技术出版社，2003年，参编 5.《胸外科特色技术》，北京科学技术出版社，2004年，副主编 6.《现代胸外科急症学》，人民军医出版社，2006年，参编 7. 《实用胸部外科学》，中国医药科技出版社，2007年，参编 8. 《外科学》，普通高等教育“十一，五”国家级规划教材，高等教育出版社，2009，参编 9. 《胸外科学》，北京大学医学出版社，北京市高等教育精品教材立项项目，2009年，参编 10. 《胸外科手术学》，人民卫生出版社，人民卫生出版社重点立项项目，2017年，主编